Author

Purva Vats

Jackson Laboratory

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Mark D. AdamsiD· 2 shared Adam P. MatsoniD· 1 shared Cameron King· 1 shared Candice N. BakeriD· 1 shared Cathleen M. LutziD· 1 shared Debra K. Duso· 1 shared Elizabeth A. WerreniD· 1 shared Frank M. SzabaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Mark D. AdamsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A de novo variant in PAK2 detected in an individual with Knobloch type 2 syndrome

Elizabeth A. Werren, Louisa Kalsner, Jessica M. Ewald, Michael Peracchio, Cameron King, Purva Vats, Peter A. Audano, Peter N. Robinson, Mark D. Adams, Melissa A. Kelly, Adam P. Matson

The paper identifies a novel de novo PAK2 variant in a patient with Knobloch syndrome type 2, supporting PAK2's role in the disorder and expanding its clinical features.

American Journal of Medical Genetics Part A · Jan 28, 2025Peer-reviewedGenomics

Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19

Candice N. Baker, Debra K. Duso, Naga Rama Kothapalli, Tricia Hart, Sean Casey, Tres S. Cookenham, Larry W. Kummer, Janine Hvizdos, Kathleen G. Lanzer, Purva Vats, Priya Shanbhag, Isaac Bell, Mike Tighe, Kelsey L. Travis, Frank M. Szaba, , Nadia A Rosenthal

The paper characterizes the CAST/EiJ mouse strain as a model for severe COVID-19 by showing it develops high viral burdens, severe lung pathology, and cytokine dysregulation leading to mortality.

Scientific Reports · Oct 24, 2024Peer-reviewedImmunology